{
    "nctId": "NCT03387059",
    "officialTitle": "A Multicentre, Prospective Randomised Controlled, Interventional Clinical Investigation to Assess the Clinical Safety and Performance of Forielle, a Medical Device for Endometrial Washing in Restoring Favorable Endometrial Condition to Implantation After COS During Assisted Reproductive Practice (ENDOMEDE)",
    "inclusionCriteria": "* All infertile women treated with intracytoplasmic sperm injection (ICSI)/Fertilization in Vitro and Embryo Transfer (FIVET)\n* Less than or equal to (\\<=) 1 previous failed embryo transfer\n* Eumenorrheic normo-gonadotropic women\n* Basal follicle-stimulating hormone (FSH) \\<=12 International unit per liter (IU/L)\n* Anti-mullerian hormone (AMH) greater than (\\>) 1.1 nanogram per milliliter (ng/mL)\n* Ovarian Reserve: number of antral follicles 2 millimeter (mm) between 6 \\<= antral follicle count (AFC) \\<= 16\n* Follicles \\> 16 mm at the triggering day between 5-14\n* Body Mass Index (BMI) between 18 \\<= BMI \\<= 27 kilogram per meter square (kg/m\\^2)\n* Indication for Fresh Embryo transfer\n* Normal uterine cavity on ultrasound exam (e.g., no presence of hydrosalpinx)\n* Undergoing Assisted Reproductive Technique (ART) and oocyte maturation by human chorionic gonadotropin (HCG) triggering\n* Progesterone (P4) serum level at the HCG triggering day \\<= 1.5 ng/mL (Day O/Randomization)\n* Estradiol (E2) \\<= 3000 picogram/milliliter (pg/mL) at the human chorionic gonadotropin (HCG) triggering day (Day 0/Randomization)\n* Subjects must have read and signed the Informed Consent Form prior to study-specific-procedures not part of standard of care\n* Other protocol defined inclusion criteria could apply\n* Must be FEMALE\n* Must have maximum age of 41 Years",
    "exclusionCriteria": "* Clinically significant systemic disease (such as diabetes, metabolic syndrome, immunological diseases, diagnosed thrombophilia, porphyria, or any other medical condition requiring the use of low-molecular weight heparin therapy)\n* Polycystic ovary syndrome (PCOS) according to Rotterdam Consensus Criteria (European Society of Human Reproduction and Embryology \\[ESHRE\\]/American Society for Reproductive Medicine \\[ASRM\\], 2003)\n* Poor ovarian response (POR) according to the European Society of Human Reproduction and Embryology (ESHRE) Criteria\n* RIF (repeated implantation failure), defined as greater than or equals to (\\>=) 2 previous failed embryo transfers\n* Endometriosis III-IV stage or adenomyosis\n* Clinically significant findings on exam or ultrasound, such as salpingitis, hydrosalpynx or evidence of ovarian cysts\n* Known hypersensitivity to any of the components of the solution\n* Known hypersensitivity to vaginal progesterone or its excipients\n* Other protocol defined exclusion criteria could apply"
}